NO751973L - - Google Patents

Info

Publication number
NO751973L
NO751973L NO751973A NO751973A NO751973L NO 751973 L NO751973 L NO 751973L NO 751973 A NO751973 A NO 751973A NO 751973 A NO751973 A NO 751973A NO 751973 L NO751973 L NO 751973L
Authority
NO
Norway
Prior art keywords
compound
group
groups
toxic
general formula
Prior art date
Application number
NO751973A
Other languages
English (en)
Norwegian (no)
Inventor
A N Howard
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of NO751973L publication Critical patent/NO751973L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
NO751973A 1974-06-04 1975-06-04 NO751973L (is")

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB24794/74A GB1501096A (en) 1974-06-04 1974-06-04 Methods and pharmaceutical preparation for the treatment of hypercholesterolaemia

Publications (1)

Publication Number Publication Date
NO751973L true NO751973L (is") 1975-12-05

Family

ID=10217337

Family Applications (1)

Application Number Title Priority Date Filing Date
NO751973A NO751973L (is") 1974-06-04 1975-06-04

Country Status (17)

Country Link
US (1) US4041153A (is")
JP (1) JPS5112934A (is")
BE (1) BE829859A (is")
CA (1) CA1038291A (is")
DE (1) DE2524882A1 (is")
DK (1) DK248975A (is")
FI (1) FI751630A7 (is")
FR (1) FR2273517A1 (is")
GB (1) GB1501096A (is")
IE (1) IE41074B1 (is")
IL (1) IL47378A (is")
NL (1) NL7506609A (is")
NO (1) NO751973L (is")
NZ (1) NZ177627A (is")
PH (1) PH13199A (is")
SE (1) SE7506293L (is")
ZA (1) ZA753615B (is")

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4180566A (en) * 1978-05-15 1979-12-25 W. R. Grace & Co. Silica gel method of reducing blood lipid concentration
FR2574295B1 (fr) * 1984-12-07 1988-02-26 Rech Etu Therapeutiques Medicaments a base de gluconate de zinc utiles pour le traitement des hyperprolactinemies
US4790991A (en) * 1985-02-05 1988-12-13 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4851392A (en) * 1985-02-05 1989-07-25 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4818539A (en) * 1985-02-05 1989-04-04 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4747881A (en) * 1985-02-05 1988-05-31 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4843098A (en) * 1985-02-05 1989-06-27 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4759923A (en) * 1987-06-25 1988-07-26 Hercules Incorporated Process for lowering serum cholesterol using poly(diallylmethylamine) derivatives
US5025037A (en) * 1989-11-03 1991-06-18 Livingston William H Uses for the oral use of oak poison preventative in the treatment of: feline leukemia, increased wool production in sheep, and reduction of shipping fever in stressed animals
RU2157199C2 (ru) * 1998-04-03 2000-10-10 Вахрушев Яков Максимович Способ лечения хронического панкреатита
US20050106267A1 (en) 2003-10-20 2005-05-19 Framework Therapeutics, Llc Zeolite molecular sieves for the removal of toxins

Also Published As

Publication number Publication date
FR2273517A1 (fr) 1976-01-02
AU8159375A (en) 1976-12-02
DE2524882A1 (de) 1975-12-18
IE41074B1 (en) 1979-10-10
CA1038291A (en) 1978-09-12
IL47378A0 (en) 1975-08-31
FR2273517B1 (is") 1978-10-06
BE829859A (fr) 1975-12-04
NZ177627A (en) 1978-04-03
JPS5112934A (is") 1976-01-31
PH13199A (en) 1980-01-28
US4041153A (en) 1977-08-09
DK248975A (da) 1975-12-05
SE7506293L (sv) 1975-12-05
FI751630A7 (is") 1975-12-05
IL47378A (en) 1978-06-15
GB1501096A (en) 1978-02-15
IE41074L (en) 1975-12-04
ZA753615B (en) 1977-02-23
NL7506609A (nl) 1975-12-08

Similar Documents

Publication Publication Date Title
US7229613B2 (en) Method for lowering serum glucose
JP4420143B2 (ja) 高コレステロール血症を治療するためのポリアリルアミンポリマー
US3499960A (en) Palatable coated particles of an anion exchange resin
DE69833134T2 (de) Verwendung aliphatischer amine zur verminderung von oxalat
US4340585A (en) Salified anionic resin for cholesterol and lipid lowering
US4143130A (en) Method for treating kidney stones
US4814354A (en) Lipid regulating agents
EP1416942B1 (en) Amine polymers for treating gout and binding uric acid
US20080085872A1 (en) Methods of treating Syndrome X with aliphatic polyamines
US20020187120A1 (en) Method for treating gout and reducing serum uric acid
ZA200308063B (en) Method of lowering serum glucose.
NO751973L (is")
JPH02214711A (ja) ポリビニルピリジニウムアニオン交換樹脂
US4064234A (en) Methods and pharmaceutical preparation for the treatment of hypercholesterolemia
US5807582A (en) Fine-beaded colestipol hydrochloride and pharmaceutically elegant dosage forms made therefrom
DK173651B1 (da) Fremgangsmåde til fremstilling af colestipol-hydrochlorid, colestipol-hydrochlorid i form af fine perler, farmaceutisk præparat samt næringsmiddelprodukt og anvendelse af colestipol-hydrochloridet i form af fine perler
JPH0330839A (ja) ポリスチレンアニオン交換ポリマー
NO874040L (no) Behandlet lipidregulator.
RU2209087C2 (ru) Агент для пролонгирования действия лекарственного препарата и лекарственная композиция на его основе
EP1923064B1 (en) Use of amine polymer for lowering serum glucose
JPH04503962A (ja) 微細ビーズ化コレスチポール塩酸塩